Applications now open!
The Brain Tumour Research Novel Therapeutics Accelerator (BTR-NTA) is an accelerator programme that provides independent and holistic guidance to help researchers position their therapeutic or technology along a realistic pathway to clinical trials.
Why the BTR-NTA was launched
Despite there being several encouraging pre-clinical studies, few brain tumour therapeutics make it to successful human trials due to barriers throughout the drug development pathway.
The BTR-NTA programme aims to help researchers address these barriers by:
- Highlighting potential pitfalls or risks in their project
- Giving multi-disciplinary feedback on work to date
- Providing constructive guidance on future work and next steps
- Recommending potential avenues for partnerships or funding
- Strengthening international collaboration in the brain tumour field
The ultimate goal of BTR-NTA is to provide guidance to enable researchers working on promising therapeutics.
FIND OUT MORE AND APPLYApplications close on 21st July 2023